Home > Quotes > SKS > Guru Analysis > Kenneth Fisher

Kenneth Fisher Guru Analysis for Saks Incorporated

SKS 
$13.31
*  
1.03
  negative  
8.39%
Get SKS Alerts
*Delayed - data as of May 21, 2013 12:52 ET 
Exchange: NYSE
Industry: Consumer Services
Community Rating:
View:    SKS Real Time
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time

Assessments & Analysis Based on May 20, 2013 close price: $12.28

  for the Price/Sales Investor based on the criteria of Kenneth Fisher. Return to SKS Guru Analysis

All Star Guru Scorecard

Source Go Chart %
Peter Lynch 0%
Benjamin Graham 43%
Validea 36%
Motley Fool 19%
David Dreman 21%
Martin Zweig 38%
Kenneth Fisher 80%
James P. O'Shaughnessy 50%

   

Detailed Analysis

Guru Score: 80%

PRICE/SALES RATIO: [PASS]

The prospective company should have a low Price/Sales ratio. Smokestack (cyclical) companies with a Price/Sales ratio between .4 and .8 represent good values according to this methodology. SKSpasses this test as its P/S of 0.59 Based on trailing 12 month sales, falls within the "good values" range for cyclical companies.


TOTAL DEBT/EQUITY RATIO: [PASS]

Less debt equals less risk according to this methodology. SKS's Debt/Equity of 31.27% is acceptable, thus passing the test.


PRICE/RESEARCH RATIO: [PASS]

This methodology considers companies in the Technology and Medical sectors to be attractive if they have low Price/Research ratios. SKS is neither a Technology nor Medical company. Therefore the Price/Research ratio is not available and, hence, not much emphasis should be placed on this particular variable.


PRELIMINARY GRADE: Some Interest in SKS At this Point

Is SKS a "Super Stock"? NO


PRICE/SALES RATIO: [PASS]

The prospective company should have a low Price/Sales ratio. Non-Smokestack(non-cyclical) companies with a Price/Sales ratio between .75 and 1.5 are good values. Otherwise, Smokestack(cyclical) companies with a Price/Sales ratio between .4 and .8 represent good values. SKS's P/S ratio of 0.59 falls within the "good values " range for cyclical industries and is considered attractive.


LONG-TERM EPS GROWTH RATE: [FAIL]

This methodology looks for companies that have an inflation adjusted EPS growth rate greater than 15%. SKS's inflation adjusted EPS growth rate of 6.85% fails the test.


FREE CASH PER SHARE: [PASS]

This methodology looks for companies that have a positive free cash per share. Companies should have enough free cash available to sustain three years of losses. This is based on the premise that companies without cash will soon be out of business. SKS's free cash per share of 0.26 passes this criterion.


THREE YEAR AVERAGE NET PROFIT MARGIN: [FAIL]

This methodology looks for companies that have an average net profit margin of 5% or greater over a three year period. SKS, whose three year net profit margin averages 2.07%, fails this evaluation.


 
  The names of individual investment advisors (i.e., the 'gurus') appearing ON THIS WEBSITE are for identification purposes ONLY. The names are used to identify the methodology as derived from the guru�s published sources. The names of the individual gurus are not intended to suggest or imply any affiliation with or endorsement of, or even any agreement with the information displayed on this website personally by such gurus, or any knowledge or approval by such persons of the content on this website. All trademarks, service marks and trade names appearing on this website are the property of their respective owners, and are likewise used for identification purposes only.
  The NASDAQ Stock Market, Inc. ("NASDAQ"), its affiliates, third party information providers, or any of these entities� officers, employees, directors, or agents have not: (1) passed on the merit of the information provided on this website or on any of these securities; or (2) endorsed or sponsored any of these securities. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED. The information contained on this website is provided for informational purposes only. See Full Disclaimer Below
See Full Disclaimer